SNPMiner Trials by Shray Alag


SNPMiner SNPMiner Trials (Home Page)


Report for SNP rs10930214

Developed by Shray Alag, 2020.
SNP Clinical Trial Gene

There is one clinical trial.

Clinical Trials


1 The Impact of the Single Nucleotide Polymorphisms rs6746030,rs7604448, rs10930214, s7595255 in SCN9A Gene on Postoperative Pain and Analgesic Consumption After Cesarean Section

The purpose of this study to determine the association between postoperative pain after cesarean section and several single nucleotide polymorphisms in SCN9A sodium channels gene.

NCT02496455 Pain, Postoperative Pregnancy Procedure: cesarean section Drug: Opioid Tramadol
MeSH: Pain, Postoperative

The Impact of the Single Nucleotide Polymorphisms rs6746030,rs7604448, rs10930214, s7595255 in SCN9A Gene on Postoperative Pain and Analgesic Consumption After Cesarean Section.

Primary Outcomes

Description: The pain will be evaluated with the visual analog scale

Measure: Pain

Time: up to postoperative 24 hours

Secondary Outcomes

Description: The total amount of the tramadol administered to the patient will be recorded

Measure: Opioid consumption

Time: Up to postoperative 24 hours


HPO Nodes